Medicamen Organics Limited
Incorporated in 1995, Medicamen Organics Limited develops pharmaceutical dosages including generic doses in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders.
What Medicamen files
- Others49
- Important35
- Board Meeting12
- Updates12
- Investor Meet7
- PPTs2
Medicamen Organics provided shareholders web links to the FY25-26 Annual Report and 31st AGM notice. The AGM will be held virtually. Shareholders are urged to update their KYC details for seamless communication and payments.
Medicamen Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Medicamen Organics Limited has informed the Exchange about Copy of Newspaper Publication for information regarding dispatch of Annual Report for the Financial Year 2025-26 and Notice of the 31st Annual General Meeting
Medicamen Organics Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026 along with the Annual Report for the financial year 2025-26.
Medicamen Organics Limited has informed the Exchange about Copy of Newspaper Publication regarding information before dispatch of notice of the 31st Annual General Meeting and Annual Report for the financial year ended March 31, 2026